[Treatment of Raynaud's phenomenon]

Harefuah. 1993 Mar 1;124(5):288-91.
[Article in Hebrew]
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenergic alpha-Antagonists / pharmacokinetics
  • Adrenergic alpha-Antagonists / therapeutic use
  • Anabolic Agents / pharmacokinetics
  • Anabolic Agents / therapeutic use
  • Humans
  • Prostaglandins / pharmacokinetics
  • Prostaglandins / therapeutic use
  • Raynaud Disease / drug therapy*
  • Raynaud Disease / therapy
  • Vasodilator Agents / pharmacokinetics
  • Vasodilator Agents / therapeutic use

Substances

  • Adrenergic alpha-Antagonists
  • Anabolic Agents
  • Prostaglandins
  • Vasodilator Agents